EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB. #57
Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: Evolution In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 191-226. 1.2 MB. https://doi.org/10.1007/164_2018_144 #108
McLaughlin, G; Morris, N; Kavanagh, PV; Power, JD; Twamley, B; O'Brien, J; Talbot, B; Dowling, G; Brandt, SD. The synthesis and characterization of the ‘research chemical’ N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide (3,5-AB-CHMFUPPYCA) and differentiation from its 5,3-regioisomer Drug Test. Anal., 1 Sep 2016, 8 (9), 920-929. 1.8 MB. https://doi.org/10.1002/dta.1864 #3,5-AB-CHMFUPPYCA LC,MS,NMR,other
5,3-AB-CHFUPYCA · AB-CHFUPYCA · AB-CHMFUPPYCA · AMB-CHM5FUPPYZ3CA